Clinical trial
Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication - A Prospective, Comparative Study
NCT01163435 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori Eradication - A Prospective, Comparative Study
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- October 31, 2013
- Enrollment
- 618 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter infection